GSH-Depleted Platinum(II) Metallacycles to Turn On the NIR Emission in Boosting Synergistic Cancer Therapy

Qifei Shen , Kai Gao , Peijuan Zhang , Xuwei Luo , Jianye Yang , Pei Zhou , Yanzi Xu , Changhuo Xu , Lingjie Meng , Heng Wang , Chao Chen , Mingming Zhang , Dongfeng Dang

Aggregate ›› 2026, Vol. 7 ›› Issue (1) : e70215

PDF
Aggregate ›› 2026, Vol. 7 ›› Issue (1) :e70215 DOI: 10.1002/agt2.70215
RESEARCH ARTICLE
GSH-Depleted Platinum(II) Metallacycles to Turn On the NIR Emission in Boosting Synergistic Cancer Therapy
Author information +
History +
PDF

Abstract

Agents to combine functions simultaneously are highly needed but still challenging in synergistic therapy. Particularly, capabilities to deplete glutathione (GSH) in tumors and monitor their process are also important. Therefore, platinum(II) metallacycles are prepared by using aggregation-induced emission active ligands. Despite their similar structures, high emission for Mh1 is obtained (PLQY = 49.2%) in solids, but a PLQY of only 6.8% is recorded for Mh2. NIR emission in Mh2 can be turned-on in depleting GSH by releasing emissive ligands. Also, both type I and type II reactive oxygen species (ROS) are obtained in Mh2 nanoparticles. Due to the depletion of GSH and generation of ROS, oxidative stress in immunogenic cell death can be induced. By combining chemotherapy and photoimmunotherapy, synergistic therapy in vivo is obtained for Mh2-NPs to well inhibit the tumor growth, also showing antitumor immune effects in distant tumors. The work here provides some guidelines in designing the multi-functional agents, showing the great potentials in efficient cancer therapy.

Keywords

aggregation-induced emission / photoimmunotherapy / platinum(II) metallacycles / reactive oxygen species / synergistic therapy

Cite this article

Download citation ▾
Qifei Shen, Kai Gao, Peijuan Zhang, Xuwei Luo, Jianye Yang, Pei Zhou, Yanzi Xu, Changhuo Xu, Lingjie Meng, Heng Wang, Chao Chen, Mingming Zhang, Dongfeng Dang. GSH-Depleted Platinum(II) Metallacycles to Turn On the NIR Emission in Boosting Synergistic Cancer Therapy. Aggregate, 2026, 7(1): e70215 DOI:10.1002/agt2.70215

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

K. E. Visser and J. A. Joyce, “The Evolving Tumor Microenvironment: From Cancer Initiation to Metastatic Outgrowth,” Cancer Cell 41 (2023): 374–403.

[2]

J. N. Hao, K. M. Ge, G. L. Chen, B. Dai, and Y. S. Li, “Strategies to Engineer Various Nanocarrier-Based Hybrid Catalysts for Enhanced Chemodynamic Cancer Therapy,” Chemical Society Reviews 52 (2023): 7707–7736.

[3]

A. Sharma, P. Verwilst, M. L. Li, et al., “Theranostic Fluorescent Probes,” Chemical Reviews 124 (2024): 2699–2804.

[4]

J. Qi, H. L. Ou, Q. Liu, and D. Ding, “Gathering Brings Strength: How Organic Aggregates Boost Disease Phototheranostics,” Aggregate 2 (2021): 95–113.

[5]

K. X. Teng, D. S. Zhang, B. K. Liu, Z. F. Liu, L. Y. Niu, and Q. Z. Yang, “Photo-Induced Disproportionation-Mediated Photodynamic Therapy: Simultaneous Oxidation of Tetrahydrobiopterin and Generation of Superoxide Radicals,” Angewandte Chemie International Edition 63 (2024): e202318783.

[6]

P. H. Xiao, W. Xie, J. Y. Zhang, et al., “De Novo Design of Reversibly pH-Switchable NIR-II Aggregation-Induced Emission Luminogens for Efficient Phototheranostics of Patient-Derived Tumor Xenografts,” Journal of the American Chemical Society 145 (2023): 334–344.

[7]

M. M. He, M. Xiao, R. Wang, J. L. Fan, X. J. Peng, and W. Sun, “Phototherapeutic Nanoagents for Cancer Immunotherapy,” Progress in Materials Science 147 (2025): 101347.

[8]

C. Wang, W. B. Zhong, X. H. Sun, et al., “NIR-Activable Charge Transfer Agents for Synergistic Photoimmunotherapy,” Angewandte Chemie International Edition 64 (2025): e202416828.

[9]

J. W. Tian, B. W. Li, C. Z. Wu, and B. Liu, “Programmable Singlet Oxygen Battery for Automated Photodynamic Therapy Enabled by Pyridone–Pyridine Tautomer Engineering,” Journal of the American Chemical Society 146 (2024): 16458–16468.

[10]

K. X. Teng, L. Y. Niu, and Q. Z. Yang, “Supramolecular Photosensitizer Enables Oxygen-Independent Generation of Hydroxyl Radicals for Photodynamic Therapy,” Journal of the American Chemical Society 145 (2023): 4081–4087.

[11]

T. C. Pham, V. N. Nguyen, Y. Choi, S. Y. Lee, and J. Y. Yoon, “Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy,” Chemical Reviews 121 (2021): 13454–13619.

[12]

Y. L. Xua, C. L. Li, X. Ma, et al., “Long Wavelength–Emissive Ru(II) Metallacycle–Based Photosensitizer Assisting in vivo Bacterial Diagnosis and Antibacterial Treatment,” Proceedings of the National Academy of Sciences of the United States of America 119 (2022): e2209904119.

[13]

Y. L. Xu, C. L. Li, J. S. An, et al., “Construction of a 980 nm laser-activated Pt(II) metallacycle nanosystem for efficient and safe photo-induced bacteria sterilization,” Science China Chemistry 66 (2023): 155–163.

[14]

Y. Qin, L. J. Chen, F. Y. Dong, et al., “Light-Controlled Generation of Singlet Oxygen Within a Discrete Dual-Stage Metallacycle for Cancer Therapy,” Journal of the American Chemical Society 141 (2019): 8943–8950.

[15]

Y. Sun, C. Y. Chen, J. B. Liu, and P. J. Stang, “Recent Developments in the Construction and Applications of Platinum-Based Metallacycles and Metallacages Via Coordination,” Chemical Society Reviews 49 (2020): 3889–3919.

[16]

Y. Sun and P. J. Stang, “Metallacycles, Metallacages, and Their Aggregate/Optical Behavior,” Aggregate 2 (2021): e94.

[17]

Y. L. Xu, Y. Dou, Q. Li, et al., “When Near-Infrared Fluorescence Meets Supramolecular Coordination Complexes: Challenges and Opportunities of Metallacycles/Metallacages in Precision Biomedicine,” Coordination Chemistry Reviews 493 (2023): 215320.

[18]

D. D. Xu, Y. Li, S. C. Yin, and F. H. Huang, “Strategies to Address Key Challenges of Metallacycle/Metallacage-Based Supramolecular Coordination Complexes in Biomedical Applications,” Chemical Society Reviews 53 (2024): 3167–3204.

[19]

Y. P. Wang, Y. Zhang, X. H. Duan, et al., “Recent Progress in Metal-Organic Cages for Biomedical Application: Highlighted Research During 2018–2023,” Coordination Chemistry Reviews 501 (2024): 215570.

[20]

Y. Li, F. H. Huang, P. J. Stang, and S. C. Yin, “Supramolecular Coordination Complexes for Synergistic Cancer Therapy,” Accounts of Chemical Research 57 (2024): 1174–1187.

[21]

W. Z. Li, X. Q. Wang, L. R. Liu, et al., “Supramolecular Coordination Platinum Metallacycle-Based Multilevel Wound Dressing for Bacteria Sensing and Wound Healing,” Proceedings of the National Academy of Sciences of the United States of America 121 (2024): e2318391121.

[22]

X. J. Lin, F. Chen, X. J. Yu, et al., “Phenylthiol-BODIPY-Based Supramolecular Metallacycles for Synergistic Tumor Chemo-Photodynamic Therapy,” Proceedings of the National Academy of Sciences of the United States of America 119 (2022): e2203994119.

[23]

C. L. Li, L. Tu, Y. L. Xu, et al., “A NIR-Light-Activated and Lysosomal-Targeted Pt(II) Metallacycle for Highly Potent Evoking of Immunogenic Cell Death that Potentiates Cancer Immunotherapy of Deep-Seated Tumors,” Angewandte Chemie International Edition 63 (2024): e202406392.

[24]

Y. X. Xiong, C. Xiao, Z. F. Li, and X. L. Yang, “Engineering Nanomedicine for Glutathione Depletion-Augmented Cancer Therapy,” Chemical Society Reviews 50 (2021): 6013–6041.

[25]

B. Y. Niu, K. X. Liao, Y. X. Zhou, et al., “Application of Glutathione Depletion in Cancer Therapy: Enhanced ROS-Based Therapy, Ferroptosis, and Chemotherapy,” Biomaterials 277 (2021): 121110.

[26]

Y. W. Wang, Y. M. Li, Z. J. Zhang, L. Wang, D. Wang, and B. Z. Tang, “Triple-Jump Photodynamic Theranostics: MnO 2 Combined Upconversion Nanoplatforms Involving a Type-I Photosensitizer With Aggregation-Induced Emission Characteristics for Potent Cancer Treatment,” Advanced Materials 33 (2021): 2103748.

[27]

G. B. Yang, D. D. Wang, S. Z. F. Phua, et al., “Albumin-Based Therapeutics Capable of Glutathione Consumption and Hydrogen Peroxide Generation for Synergetic Chemodynamic and Chemotherapy of Cancer,” ACS Nano 16 (2022): 2319–2329.

[28]

Z. W. Zhou, H. Liang, R. Y. Yang, et al., “Glutathione Depletion-Induced Activation of Dimersomes for Potentiating the Ferroptosis and Immunotherapy of “Cold” Tumor,” Angewandte Chemie International Edition 61 (2022): e202202843.

[29]

Y. Chen, P. Y. He, D. Jana, et al., “Glutathione-Depleting Organic Metal Adjuvants for Effective NIR-II Photothermal Immunotherapy,” Advanced Materials 34 (2022): 2201706.

[30]

Z. X. Zhou, J. P. Liu, J. J. Huang, et al., “A Self-Assembled Ru–Pt Metallacage as a Lysosome-Targeting Photosensitizer for 2-Photon Photodynamic Therapy,” Proceedings of the National Academy of Sciences of the United States of America 116 (2019): 20296–20302.

[31]

C. L. Li, Y. D. Pang, Y. L. Xu, et al., “Near-Infrared Metal Agents Assisting Precision Medicine: From Strategic Design to Bioimaging And Therapeutic Applications,” Chemical Society Reviews 52 (2023): 4392–4442.

[32]

J. L. Zhu, L. Xu, Y. Y. Ren, et al., “Switchable Organoplatinum Metallacycles With High Quantum Yields and Tunable Fluorescence Wavelengths,” Nature Communications 10 (2019): 4285.

[33]

X. Y. Kang, Y. Zhang, J. W. Song, et al., “A Photo-Triggered Self-Accelerated Nanoplatform for Multifunctional Image-Guided Combination Cancer Immunotherapy,” Nature Communications 14 (2023): 5216.

[34]

L. Tu, C. L. Li, Q. H. Ding, et al., “Augmenting Cancer Therapy With a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle,” Journal of the American Chemical Society 146 (2024): 8991–9003.

[35]

N. Feng, Z. Peng, X. Zhang, et al., “Strategically Engineered Au(I) Complexes for Orchestrated Tumor Eradication Via Chemo-Phototherapy and Induced Immunogenic Cell Death,” Nature Communications 15 (2024): 8187.

[36]

P. Jeyakkumar, Y. P. Liang, M. Y. Guo, et al., “Emissive Metallacycle-Crosslinked Supramolecular Networks With Tunable Crosslinking Densities for Bacterial Imaging and Killing,” Angewandte Chemie International Edition 59 (2020): 15199–15203.

[37]

K. Gao, Z. Y. Zhang, L. Z. Ma, et al., “Reversible Supramolecular Adhesives Formed by Metallacycle-Crosslinked Polymer Networks Via Amino‑Yne Click Reaction,” Giant 4 (2020): 100034.

[38]

Y. H. Duo, L. Han, Y. Q. Yang, et al., “Aggregation-Induced Emission Luminogen: Role in Biopsy for Precision Medicine,” Chemical Reviews 124 (2024): 11242–11347.

[39]

C. Chen, X. Y. Zhang, Z. Y. Gao, G. X. Feng, and D. Ding, “Preparation of Aiegen-Based Near-Infrared Afterglow Luminescence Nanoprobes For Tumor Imaging And Image-Guided Tumor Resection,” Nature Protocols 19 (2024): 2408–2434.

[40]

C. Chen, H. Q. Gao, H. L. Ou, et al., “Amplification of Activated Near-Infrared Afterglow Luminescence by Introducing Twisted Molecular Geometry for Understanding Neutrophil-Involved Diseases,” Journal of the American Chemical Society 144 (2022): 3429–3441.

[41]

Y. Z. Xu, H. K. Zhang, N. Zhang, et al., “An Easily Synthesized AIE luminogen for Lipid Droplet-Specific Super-Resolution Imaging and Two-Photon Imaging,” Materials Chemistry Frontiers 5 (2021): 1872–1883.

[42]

W. J. Chi, J. Chen, W. J. Liu, et al., “A General Descriptor Δ E Enables the Quantitative Development of Luminescent Materials Based on Photoinduced Electron Transfer,” Journal of the American Chemical Society 142 (2020): 6777–6785.

[43]

R. H. Xu, D. F. Dang, Z. Wang, et al., “Facilely Prepared Aggregation-Induced Emission (AIE) Nanocrystals With Deep-Red Emission for Super-Resolution Imaging,” Chemical Science 13 (2022): 1270–1280.

[44]

R. H. Xu, W. J. Chi, Y. Z. Zhao, et al., “All-in-One Theranostic Platforms: Deep-Red AIE Nanocrystals to Target Dual-Organelles for Efficient Photodynamic Therapy,” ACS Nano 16 (2022): 20151–20162.

[45]

R. H. Xu, Q. F. Shen, P. J. Zhang, et al., “Less is More: Asymmetric D–A Type Agent to Achieve Dynamic Self-Assembled Nanoaggregates for Long-Acting Photodynamic Therapy,” Advanced Materials 36 (2024): 2402434.

[46]

M. Maiuri, M. Garavelli, and G. Cerullo, “Ultrafast Spectroscopy: State of the Art and Open Challenges,” Journal of the American Chemical Society 142 (2020): 3–15.

[47]

M. M. Zhang, M. L. Saha, M. Wang, et al., “Multicomponent Platinum(II) Cages With Tunable Emission and Amino Acid Sensing,” Journal of the American Chemical Society 139 (2017): 5067–5074.

[48]

Z. Wang, Y. Zhou, Y. Hao, et al., “One Stone, Two Birds: High-Brightness Aggregation-Induced Emission Photosensitizers for Super-Resolution Imaging and Photodynamic Therapy,” Nano Letters 24 (2024): 3005–3013.

[49]

K. J. Hiam-Galvez, B. M. Allen, and M. H. Spitzer, “Systemic Immunity in Cancer,” Nature Reviews Cancer 21 (2021): 345–359.

[50]

F. X. Liu, S. P. Ning, X. Wang, et al., “Pulsatile Sequential Drug Release System for Cascade Tumor Deep Penetration and Differentiation Therapy to Enhance Chemoimmunotherapy,”Science Advances 11 (2025): eadr8001.

[51]

Y. J. Yu, D. S. Wei, T. J. Bing, Y. H. Wang, C. Y. Liu, and H. H. Xiao, “A Polyplatin With Hands-Holding Near-Infrared-II Fluorophores and Prodrugs at a Precise Ratio for Tracking Drug Fate With Realtime Readout and Treatment Feedback,” Advanced Materials 36 (2024): 2402452.

[52]

Q. F. Shen, K. Gao, P. J. Zhang, et al., “Highly Emissive Platinum(II) Metallacage in the Near-Infrared Region for Synergistic Chemo-Photodynamic Therapy,” Journal of Medicinal Chemistry 68 (2025): 7780–7791.

[53]

X. Y. Kang, Y. Zhang, J. W. Song, et al., “A Photo-Triggered Self-Accelerated Nanoplatform for Multifunctional Image-Guided Combination Cancer Immunotherapy,” Nature Communications 14 (2023): 5216.

RIGHTS & PERMISSIONS

2025 The Author(s). Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.

PDF

3

Accesses

0

Citation

Detail

Sections
Recommended

/